Showing results (91-100 of 651) with videos related to

Sort By:
Pageof 66
Kidney International|January 29, 2011
Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathyStine E Nielsen, Steen Andersen, Dietmar Zdunek, et al.
Current Pharmaceutical Design|June 24, 2017
Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and CancerJens Oellgaard, Signe Abitz Winther, Tobias Schmidt Hansen, et al.
British Journal of Clinical Pharmacology|April 16, 2015
The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markersBauke Schievink, Dick de Zeeuw, Hans-Henrik Parving, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 6, 2021
Urinary peptidome and diabetic retinopathy in the DIRECT-Protect 1 and 2 trialsViktor Rotbain Curovic, Pedro Magalhães, Tianlin He, et al.
The International Journal of Cardiovascular Imaging|January 23, 2016
Cardiac time intervals and the association with 2D-speckle-tracking, tissue Doppler and conventional echocardiography: the Thousand&1 StudyTor Biering-Sørensen, Jan Skov Jensen, Henrik Ullits Andersen, et al.
Journal of Diabetes and Its Complications|September 9, 2015
The influence of pharmaceutically induced weight changes on estimates of renal function: A patient-level pooled analysis of seven randomised controlled trials of glucose lowering medicationBernt Johan von Scholten, David Dynnes Ørsted, Anne Louise Svendsen, et al.
Diabetes Care|June 22, 2019
Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without AlbuminuriaDorte Vistisen, Gregers Stig Andersen, Adam Hulman, et al.
Ugeskrift for Laeger|August 25, 2020
[SGLT 2 inhibitors in Type 1 diabetes]Elisabeth Buur Stougaard, Hanan Amadid, Esben Søndergaard, et al.
British Journal of Clinical Pharmacology|December 30, 2025
The association between mineralocorticoid receptor antagonist use and diabetes occurrence and progression: A systematic review and meta-analysisMehmet Kanbay, Mustafa Guldan, Lasin Ozbek, et al.
Diabetologia|June 1, 2018
Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 studyJens Oellgaard, Peter Gæde, Peter Rossing, et al.
Pageof 66